Cognitive genomics
This article may require cleanup to meet Wikipedia's quality standards. The specific problem is: Reads like a class assignment, contains much irrelevant stuff (e.g. section on imaging techniques). (April 2015) |
Cognitive genomics (or neurative genomics) is the sub-field of genomics pertaining to cognitive function in which the genes and non-coding sequences of an organism's genome related to the health and activity of the brain are studied. By applying comparative genomics, the genomes of multiple species are compared in order to identify genetic and phenotypical differences between species. Observed phenotypical characteristics related to the neurological function include behavior, personality, neuroanatomy, and neuropathology. The theory behind cognitive genomics is based on elements of genetics, evolutionary biology, molecular biology, cognitive psychology, behavioral psychology, and neurophysiology.
Intelligence is the most extensively studied behavioral trait.[1] In humans, approximately 70% of all genes are expressed in the brain.[2] Genetic variation accounts for 40% of phenotypical variation.[3] Approaches in cognitive genomics have been used to investigate the genetic causes for many mental and neurodegenerative disorders including Down syndrome, major depressive disorder, autism, and Alzheimer's disease.
Cognitive genomics testing edit
Approaches edit
Evo-geno edit
The most commonly used approach to genome-investigation is evolutionary genomics biology, or evo-geno, in which the genomes of two species which share a common ancestor are compared.[4] A common example of evo-geno is comparative cognitive genomics testing between humans and chimpanzees which shared an ancestor 6-7 million years ago.[5] Patterns in local gene expression and gene splicing are examined to determine genomic differentiation. Comparative transcriptomic analyses conducted on primate brains to measure gene expression levels have shown significant differences between human and chimpanzee genomes.[4] The evo-geno approach was also used to verify the theory that humans and non-human primates share similar expression levels in energy metabolism-related genes which have implications for aging and neurodegenerative disease.[4]
Evo-devo edit
Evolutionary development biology (evo-devo) approach compares cognitive and neuroanatomic development patterns between sets of species. Studies of human fetus brains reveal that almost a third of expressed genes are regionally differentiated, far more than non-human species.[4] This finding could potentially explain variations in cognitive development between individuals. Neuroanatomical evo-devo studies have connected higher brain order to brain lateralization which, though present in other species, is highly ordered in humans.
Evo-pheno and evo-patho edit
Evolutionary phenotype biology (evo-pheno) approach examines phenotype expression between species. Evolutionary pathology biology (evo-patho) approach investigates disease prevalence between species.
Imaging genomics edit
Candidate gene selection edit
In genomics, a gene being imaged and analyzed is referred to as a candidate gene. The ideal candidate genes for comparative genomic testing are genes that harbor well-defined functional polymorphisms with known effects on neuroanatomical and/or cognitive function.[2] However, genes with either identified single-nucleotide polymorphisms or allele variations with potential functional implications on neuroanatomical systems suffice.[2] The weaker the connection between the gene and the phenotype, the more difficult it is to establish causality through testing.[2]
Controlling for non-genetic factors edit
Non-genetic factors such as age, illness, injury, or substance abuse can have significant effects on gene expression and phenotypic variance.[2] The identification and contribution of genetic variation to specific phenotypes can only be performed when other potential contributing factors can be matched across genotype groups.[2] In the case of neuroimaging during task performance such as in fMRI, groups are matched by performance level. Non-genetic factors have a particularly large potential effect on cognitive development. In the case of autism, non-genetic factors account for 62% of disease risk.[6]
Task selection edit
In order to study the connection between a candidate gene and a proposed phenotype, a subject is often given a task to perform that elicits the behavioral phenotype while undergoing some form of neuroimaging. Many behavioral tasks used for genomic studies are modified versions of classic behavioral and neuropsychological tests designed to investigate neural systems critical to particular behaviors.[2]
Species used in comparative cognitive genomics edit
Humans edit
In 2003, the Human Genome Project produced the first complete human genome.[7] Despite the project's success, very little is known about cognitive gene expression.[8] Prior to 2003, any evidence concerning human brain connectivity was based on post-mortem observations.[9] Due to ethical concerns, no invasive in vivo genomics studies have been performed on live humans.[citation needed]
Non-human primates edit
As the closest genetic relatives to humans, non-human primates are the most preferable genomics imaging subjects. In most cases, primates are imaged while under anesthesia.[8] Due to the high cost of raising and maintaining primate populations, genomic testing on non-human primates is typically performed at primate research facilities.
Chimpanzees edit
Chimpanzees (Pan troglodytes) are the closest genetic relatives to humans, sharing 93.6% genetic similarity.[10] It is believed that humans and chimpanzees shared a common genetic ancestor around 7 million years ago.[8] The movement to sequence the chimpanzee genome began in 1998 and was given high priority by the US National Institutes of Health (NIH).[11]
Currently, human and chimpanzees have the only sequenced genomes in the extended family of primates.[12] Some comparisons of autosomal intergenic non-repetitive DNA segments suggest as little as 1.24% genetic difference between humans and chimpanzees along certain sections.[13] Despite the genetic similarity, 80% of proteins between the two species are different which understates the clear phenotypical differences.[14]
Rhesus macaques edit
Rhesus macaques (Macaca mulatta) exhibit a 93% genetic similarity to humans approximately.[15] They are often used as an out-group in human/chimpanzee genomic studies.[8] Humans and rhesus macaques shared a common ancestor an estimated 25 million years ago.[5]
Apes edit
Orangutans (Pongo pygmaeus) and gorillas (Gorilla gorilla) have been used in genomics testing but are not common subjects due to cost.[8]
Neurobehavioral and cognitive disorders edit
Despite what is sometimes reported, most behavioral or pathological phenotypes are not due to a single gene mutation but rather a complex genetic basis.[16] However, there are some exceptions to this rule such as Huntington's disease which is caused by a single specific genetic disorder.[16] The occurrence of neurobehavioral disorders is influenced by a number of factors, genetic and non-genetic.
Down syndrome edit
Down syndrome is a genetic syndrome marked by intellectual disability and distinct cranio-facial features and occurs in approximately 1 in 800 live births.[17] Experts believe the genetic cause for the syndrome is a lack of genes in the 21st chromosome.[17] However, the gene or genes responsible for the cognitive phenotype have yet to be discovered.
Fragile-X syndrome edit
Fragile-X syndrome is caused by a mutation of the FRAXA gene located in the X chromosome.[17] The syndrome is marked by intellectual disability (moderate in males, mild in females), language deficiency, and some autistic spectrum behaviors.[17]
Alzheimer's disease edit
Alzheimer's disease is a neurodegenerative disorder that causes age-correlated progressive cognitive decline.[17] animal model using mice have investigated the pathophysiology and suggest possible treatments such as immunization with amyloid beta and peripheral administration of antibodies against amyloid beta.[17] Studies have linked Alzheimer's with gene alterations causing SAMP8 protein abnormalities.[18]
Autism edit
Autism is a pervasive developmental disorder characterized by abnormal social development, inability to empathize and effectively communicate, and restricted patterns of interest.[17] A possible neuroanatomical cause is the presence of tubers in the temporal lobe.[17] As mentioned previously, non-genetic factors account for 62% of autism development risk.[6] Autism is a human-specific disorder. As such, the genetic cause has been implicated to highly ordered brain lateralization exhibited by humans.[4] Two genes have been linked to autism and autism spectrum disorders (ASD): c3orf58 (a.k.a. Deleted In Autism-1 or DIA1) and cXorf36 (a.k.a.Deleted in Autism-1 Related or DIA1R).[19]
Major depressive disorder edit
Major depressive disorder is a common mood disorder believed to be caused by irregular neural uptake of serotonin. While the genetic cause is unknown, genomic studies of post-mortem MDD brains have discovered abnormalities in the fibroblast growth factor system which supports the theory of growth factors playing an important role in mood disorders.[20]
Others edit
Other neurodegenerative disorders include Rett syndrome, Prader–Willi syndrome, Angelman syndrome, and Williams-Beuren syndrome.
See also edit
References edit
- ^ Plomin, Robert; Spinath, Frank M. (January 2004). "Intelligence: Genetics, Genes, and Genomics". Journal of Personality and Social Psychology. 86 (1): 112–129. CiteSeerX 10.1.1.525.3970. doi:10.1037/0022-3514.86.1.112. PMID 14717631.
- ^ a b c d e f g Hariri, Ahmad R; Weinberger, Daniel R (March 2003). "Imaging genomics". British Medical Bulletin. 65 (1): 259–270. doi:10.1093/bmb/65.1.259. PMID 12697630.
- ^ Plomin, Robert; Spinath, Frank M. (January 2004). (PDF). Journal of Personality and Social Psychology. 86 (1): 112–129. doi:10.1037/0022-3514.86.1.112. PMID 14717631. S2CID 5734393. Archived from the original (PDF) on 2020-07-26.
- ^ a b c d e Konopka, Genevieve; Geschwind, Daniel H. (21 October 2010). "Human Brain Evolution: Harnessing the Genomics (R)evolution to Link Genes, Cognition, and Behavior". Neuron. 68 (2): 231–244. doi:10.1016/j.neuron.2010.10.012. PMC 2993319. PMID 20955931.
- ^ a b Cáceres, Mario; Lachuer, Joel; Zapala, Matthew A.; Redmond, John C.; Kudo, Lili; Geschwind, Daniel H.; Lockhart, David J.; Preuss, Todd M.; Barlow, Carrolee (28 October 2003). "Elevated gene expression levels distinguish human from non-human primate brains". Proceedings of the National Academy of Sciences. 100 (22): 13030–13035. Bibcode:2003PNAS..10013030C. doi:10.1073/pnas.2135499100. PMC 240739. PMID 14557539.
- ^ a b Digitale, Erin (4 July 2011). "Non-genetic factors play surprisingly large role in determining autism, says study by group". Stanford School of Medicine, Stanford University.
- ^ "Human Genome Project FAQ". National Human Genome Research Institute.
- ^ a b c d e Interview with Todd Preuss, PhD, Yerkes National Primate Research Center[unreliable source?]
- ^ Behrens, T E J; Johansen-Berg, H; Woolrich, M W; Smith, S M; Wheeler-Kingshott, C A M; Boulby, P A; Barker, G J; Sillery, E L; Sheehan, K; Ciccarelli, O; Thompson, A J; Brady, J M; Matthews, P M (15 June 2003). "Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging". Nature Neuroscience. 6 (7): 750–757. doi:10.1038/nn1075. PMID 12808459. S2CID 827480.
- ^ Cohen, Jon (7 June 2007). "Relative Differences: The Myth of 1%". Science. 316 (5833): 1836. doi:10.1126/science.316.5833.1836. PMID 17600195. S2CID 84106299.
- ^ Olson, Maynard V.; Varki, Ajit (January 2003). "Sequencing the chimpanzee genome: insights into human evolution and disease". Nature Reviews Genetics. 4 (1): 20–28. doi:10.1038/nrg981. PMID 12509750. S2CID 205486561.
- ^ Goodman, Morris; Grossman, Lawrence I.; Wildman, Derek E. (September 2005). "Moving primate genomics beyond the chimpanzee genome". Trends in Genetics. 21 (9): 511–517. doi:10.1016/j.tig.2005.06.012. PMID 16009448.
- ^ Chen, Feng-Chi; Li, Wen-Hsiung (2001). "Genomic Divergences between Humans and Other Hominoids and the Effective Population Size of the Common Ancestor of Humans and Chimpanzees". American Journal of Human Genetics. 68 (2): 444–456. CiteSeerX 10.1.1.329.720. doi:10.1086/318206. PMC 1235277. PMID 11170892.
- ^ Glazko, Galina; Veeramachaneni, Vamsi; Nei, Masatoshi; Makałowski, Wojciech (February 2005). "Eighty percent of proteins are different between humans and chimpanzees". Gene. 346: 215–219. doi:10.1016/j.gene.2004.11.003. PMID 15716009.
- ^ "DNA sequence of Rhesus macaque has evolutionary, medical implications" (Press release). Baylor College of Medicine. 12 April 2007.
- ^ a b McGuffin, Peter; Riley, Brien; Plomin, Robert (16 February 2001). "Toward Behavioral Genomics". Science. 291 (5507): 1232–1249. doi:10.1126/science.1057264. PMID 11233447. S2CID 83900633.
- ^ a b c d e f g h Fisch, Gene S. (2003). Genetics and Genomics of Neurobehavioral Disorders. Humana Press. pp. 3–19. doi:10.1007/978-1-59259-353-8_1 (inactive 31 January 2024). ISBN 978-1-59259-353-8.
{{cite book}}: CS1 maint: DOI inactive as of January 2024 (link) - ^ Butterfield, D; Poon, H (October 2005). "The senescence-accelerated prone mouse (SAMP8): A model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease". Experimental Gerontology. 40 (10): 774–783. CiteSeerX 10.1.1.313.4638. doi:10.1016/j.exger.2005.05.007. PMID 16026957. S2CID 15860658.
- ^ Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E. (19 January 2011). "Characterization of the Deleted in Autism 1 Protein Family: Implications for Studying Cognitive Disorders". PLOS ONE. 6 (1): e14547. Bibcode:2011PLoSO...614547A. doi:10.1371/journal.pone.0014547. PMC 3023760. PMID 21283809.
- ^ Niculescu, Alexander B (2005). "Genomic studies of mood disorders - the brain as a muscle?". Genome Biology. 6 (4): 215. doi:10.1186/gb-2005-6-4-215. PMC 1088952. PMID 15833130.